Assembly Biosciences
First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment
June 19, 2024Research and Development Assembly Biosciences, Hepatology, clinical trial, hepatitis
Assembly Biosciences has announced that the first participant has been dosed in its phase 1b trial of ABI-4334, the company’s …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
